Celyad market cap
WebJul 16, 2024 · Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric … WebMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for Celyad (CYAD)
Celyad market cap
Did you know?
WebApr 7, 2024 · CYAD’s market cap is 18.40 Mil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. WebIntroduction of Celyad Oncology, including company profile, stock information, contact number, and company business introduction.
WebLast Five Real-Time Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs … WebMar 15, 2024 · MONT-SAINT-GUIBERT, Belgium, March 15, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced a non-cash impairment of its goodwill …
WebMar 11, 2024 · I currently hold no position in Celyad but given that there are multiple milestones and readouts expected in 2024, investors who are willing to take up a speculative position could consider... WebMarket Cap$26.78M Enterprise Value$13.85M Total Cash (Recent Filing)€14.38M Total Debt (Recent Filing)€2.16M Price to Earnings (P/E)-0.8 Beta1.61 Next EarningsMar 23, 2024 EPS Estimate-$0.83 Next Dividend Ex-DateN/A Dividend YieldN/A Share Statistics
WebMar 24, 2024 · March 24, 2024 at 02:00 AM EDT. MONT-SAINT-GUIBERT, Belgium, March 24, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, is pleased to announce Georges Rawadi as its …
WebApr 10, 2024 · Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) … christmas devotional for women\u0027s groupchristmas destinations usa with kidsWebTop market news, company earnings, real-time market data and in-depth market analysis from Moomoo. Markets . Product . Get real-time quotes and financial analysis . Stocks; Forex; Features . Explore moomoo's robust features . Screener; News . Headlines . The most important news of the day . 24/7 . christmas destinations in texasWebApr 4, 2024 · MONT-SAINT-GUIBERT, Belgium, Apr 04, 2024 (GLOBE NEWSWIRE via COMTEX) -- MONT-SAINT-GUIBERT, Belgium, April 04, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the "Company"),... germ cells are destined to becomeWebMar 23, 2024 · Celyad Oncology has a market cap or net worth of $19.60 million as of March 24, 2024. Its market cap has decreased by -61.91% in one year. Market Cap. … germ cells and somatic cellsWebProvide the latest Celyad Oncology (CYAD) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company introduction, dividends and dividend information, you can also use Moomoo to open an account to trade Celyad Oncology stocks，we will provide investors with reference decision data. christmas devotionals for ladies meetingsWebMar 2, 2024 · On Feb. 28, Celyad said it had voluntarily paused the phase 1b study (NCT04991948) — which is part of a collaboration with Merck & Co. (NYSE: MRK) — in colorectal cancer to investigate reports of... germ cell neoplasia in situ pathology